HAE

120.5100.12%
JC

James C. D'Arecca

Independent Director

Mr. James C. D'Arecca, C.P.A., is Director of Prestige Brands, Inc. from August 2023. Mr. D'Arecca joined the Prestige Brands, Inc. in August 2023. Mr. D'Arecca is Chief Financial Officer of Cardiva Medical, Inc. Mr. D'Arecca has been the Global Chief Accounting Officer of Actavis Limited since August 7, 2013. He is Executive Vice President and Chief Financial Officer of Haemonetics Corporation since April 11, 2022 and serves as its Principal Accounting Officer from August 9, 2022. He serves as Principal Financial Officer of Haemonetics Corporation. Mr. D'Arecca had been the Chief Accounting Officer of Allergan plc (formerly known as Actavis plc) since August 16, 2013 until May 8, 2020 and its Senior Vice President. He joined Actavis from Bausch & Lomb, where he served as its Chief Accounting Officer. He experience in finance leadership and strategy. Since June 2020, he has served as Chief Financial Officer of TherapeuticsMD, a women's healthcare company. He served for Merck & Co. Inc. as Business Development Controller, where he was responsible for being the primary liaison between the Controller’s organization and the business development and corporate licensing functions. Mr. D'Arecca served as an Assistant Controller of Schering-Plough. He served for 13 years with PricewaterhouseCoopers as a Certified Public Accountant. He focused on pharmaceuticals, medical devices and consumer products. He served as an Executive Director of Merck & Co. Inc. and Schering-Plough. Mr. D'Arecca has an MBA from Columbia University and has BS in Accounting from Rutgers University and is a Certified Public Accountant.

Positions